Vertebral hemangioma: typical, atypical or aggressive spinal lesion?
Vertebral hemangiomas are common benign vascular lesions found incidentally on spine imaging. Most require no treatment. A small minority are atypical or aggressive and may weaken the vertebra, extend into the epidural space or compress the spinal cord or nerve roots.
A typical hemangioma contains abundant fat and thickened vertical trabeculae. On CT, axial images can show a polka-dot pattern and sagittal images a corduroy appearance. Atypical lesions contain less fat and more vascular tissue, which can mimic metastasis or another tumour on MRI. Aggressive lesions expand the vertebral body, erode cortex, involve posterior elements or extend epidurally and can produce pain, fracture, radiculopathy or myelopathy.
Assessment and differential diagnosis
Typical lesions are often recognizable on CT and MRI. Atypical lesions may be T1 hypointense and T2 hyperintense and require comparison with CT, chemical-shift imaging, contrast enhancement, diffusion or follow-up. Aggressive features include cortical destruction, expansion, posterior-element involvement, epidural soft tissue, vertebral collapse and neural compression. When the imaging remains indeterminate—especially in a person with known cancer—specialist radiological review, advanced imaging or biopsy may be necessary. Biopsy and surgery require planning because the lesion can bleed heavily.
| Clinical pattern | Possible next step | Why it matters |
|---|---|---|
| Typical asymptomatic hemangioma | No treatment or routine follow-up | The lesion is benign and incidental. |
| Atypical but stable indeterminate lesion | Radiological comparison or follow-up | Differentiate it from metastasis or another tumour. |
| Painful lesion without neurological deficit | Vertebroplasty, ablation, embolization or radiotherapy may be considered | Treatment depends on fracture risk, anatomy and local expertise. |
| Aggressive lesion with neurological compression | Urgent specialist and surgical assessment | Decompression and haemorrhage control may be necessary. |
Treatment and decision-making
Asymptomatic typical vertebral hemangiomas require no therapy. Painful lesions may be treated with vertebroplasty, sclerotherapy, radiofrequency or ethanol ablation, embolization, radiotherapy or combinations selected by a multidisciplinary team. Aggressive lesions with neurological deficit usually require decompression and stabilization, often with preoperative embolization to reduce blood loss. The exact strategy depends on vertebral location, epidural extension, fracture, spinal stability and the expertise available. Atypical lesions should not be treated before malignancy has been reasonably excluded.
How to interpret the condition in practice
The most important distinction is not simply “hemangioma or no hemangioma,” but whether the lesion is typical, indeterminate or aggressive and whether it threatens bone or neural structures.
Look for fat
Fat-rich lesions are more typical and easier to recognize.
Look for expansion
Cortical expansion and epidural tissue suggest aggression.
Compare CT and MRI
The trabecular pattern may be clearer on CT.
Review cancer history
Atypical lesions need more caution in oncology patients.
Plan bleeding control
Biopsy and surgery may cause substantial haemorrhage.
Treat the neurological risk
Cord or root compression takes priority over the benign label.
How to monitor the condition and avoid interpretation errors
A credible plan should define what improvement means before treatment begins and should explain how the diagnosis will be reconsidered if the expected response does not occur. Pain intensity can change independently from neurological function, walking tolerance, sleep or participation. For uncommon conditions, progression and safety are often more important than day-to-day symptom fluctuation.
Create a baseline
Record symptom distribution, strength, sensation, walking, sleep, medication use and the activities that matter most.
Use a planned review point
Decide when the response will be reviewed rather than continuing automatically until a treatment package is completed.
Separate relief from diagnosis
Temporary improvement after medication, injection, manual care or a device does not prove the proposed structure was the true cause.
Watch the neurological trajectory
New weakness, spreading numbness, gait change or autonomic symptoms matter even if pain decreases.
Review alternative causes
Degenerative, inflammatory, infectious, oncological and postoperative mechanisms may overlap.
Escalate proportionately
Imaging, specialist referral or surgery should be considered when the risk or functional loss justifies it.
Common errors to avoid
- Treating the most unusual imaging finding instead of the clinically relevant lesion.
- Assuming that a stable imaging abnormality explains a changing symptom pattern.
- Using one negative test to exclude a condition that remains clinically plausible.
- Repeating passive treatment despite no measurable functional progress.
- Generalizing results from a small specialist series to every person with the same label.
- Delaying urgent assessment to complete a predetermined number of visits.
Shared decision-making is strongest when uncertainty is stated directly. A provider should explain what is confirmed, what remains probable, which alternatives still matter and what findings would change the plan. For rare or controversial diagnoses, a second opinion from a clinician experienced with the specific condition may be more useful than adding another non-specific treatment.
Questions before choosing care
What is the leading diagnosis?
Ask which symptoms and examination findings support it.
What alternative remains possible?
Common competing causes should be reviewed before an invasive procedure.
What test changes management?
Avoid testing or imaging that cannot alter the next step.
What outcome matters?
Track function, neurological safety and meaningful activity.
A single symptom, image or treatment response rarely establishes the complete cause by itself.
Relevant specialized resources
Some resources may share ownership or editorial direction; this relationship is disclosed and the links are included for contextual relevance.
Frequently asked questions
Is a vertebral hemangioma cancer?
No. It is a benign vascular lesion.
Are vertebral hemangiomas common?
Yes, especially as incidental imaging findings.
What is the polka-dot sign?
An axial CT appearance produced by thickened vertical trabeculae.
What is the corduroy sign?
A sagittal or radiographic pattern of vertical trabeculae.
Why can an atypical hemangioma mimic metastasis?
It contains less fat and more vascular tissue.
Does every hemangioma require follow-up?
No.
Can a hemangioma fracture a vertebra?
An aggressive lesion can weaken the bone.
When is embolization used?
Often before surgery or as part of selected interventional treatment.
Can vertebroplasty treat pain?
It may help selected painful lesions and stabilize the vertebra.
Does The Spine Page diagnose vertebral tumours?
No.
Sources consulted
- Kato et al. — Vertebral hemangioma diagnosis and management review
- Subramaniam et al. — Aggressive hemangioma versus metastases systematic review
- Zhang et al. — Surgical options and recommendations
Last editorial review: July 2026. General educational information only.
Dr. Sylvain Desforges, B.Sc., D.O., N.D., osteopath — The Spine Page
Continue exploring spine health
Use the condition and treatment hubs to compare related guides.
The Spine Page — The best treatments for your spinal problems — www.thespinepage.com